Health TrialsbyHealthPanel

Conservative Versus Surgical Treatment of Gartland Type II Supracondylar Humeral Fractures in Children - Which One ?

ConditionHumeral Fractures
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-12
SponsorAssiut University

About this trial

The primary aim of this research is to compare the efficacy of conservative treatment versus surgical treatment for Gartland type II supracondylar humerus fractures in children. The comparison focuses on assessing differences in clinical outcomes functional recovery times, and complication rates between the two treatment groups.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with Gartland type II supracondylar humerus fractures with age between 1-12 years old treated at the AUH

Disqualifiers

Gartland Type I, III, or IV fractures.

Open fractures.

Associated neurovascular injury (e.g., absent radial pulse, documented nerve palsy).

Patients with another injury in the same limb

Trial design

Design model

Parallel

Treatments tested in this trial

  • Conservative treatment by casting

    Other intervention

    Closed reduction of Gartland type II supracondylar humeral fracture under appropriate analgesia or anesthesia, followed by immobilization using an above-elbow cast. Patients will undergo regular clinical and radiographic follow-up to monitor fracture alignment, healing, and functional recovery.

  • surgical treatment via percutaneous pinning UGA

    Procedure/Surgery

    surgical treatment vis Closed reduction and percutaneous pinning under general anesthesia. Postoperative care includes clinical and radiographic follow-up to assess fracture healing, alignment, and potential complications.

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: Conservative treatmentExperimental treatment 1 intervention
Group B: Surgical treatment groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Functional outcome assessed by Modified Disabilities of the Arm, Shoulder and Hand (QuickDASH) score

Functional outcome will be evaluated using the Modified QuickDASH questionnaire. Scores range from 0 to 100, with higher scores indicating greater disability.

Time frame
1 year

Secondary outcomes

1

Elbow flexion range of motion (degrees)

Measured in degrees using a goniometer to assess maximum elbow flexion.

Time frame
1 month, 3 months, and 6 months post-intervention
2

Elbow extension range of motion (degrees)

Measured in degrees using a goniometer to assess maximum elbow extension.

Time frame
1 month, 3 months, and 6 months post-intervention
3

Pain assessed using Visual Analog Scale (VAS)

Pain is measured on a scale from 0 to 10, where 0 indicates no pain and 10 indicates worst possible pain.

Time frame
1 month, 3 months, and 6 months post-intervention
4

Baumann angle (degrees)

Measured on standard anteroposterior elbow radiographs to assess coronal alignment.

Time frame
Immediately post-reduction and at 6 months

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Assiut University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: